Related Experiment Video

Updated: Apr 25, 2026

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
13:47

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Published on: May 19, 2020

3.0K

Patent prospects toward therapeutics and diagnostics of anthrax

Rashi Chauhan, Gulshan Wadhwa, Sanjeev K Sharma

  • 1Department of Biotechnology, Jaypee Institute of Information Technology, A-10, Sector-62, NOIDA- 201307, Uttar Pradesh, India. ckj522@yahoo.com.

Recent Patents on Anti-Infective Drug Discovery
|August 23, 2014
PubMed

Insights

Anthrax remains a deadly disease despite antibiotics. New therapies targeting Bacillus anthracis toxins (protective antigen, edema factor, lethal factor) and capsule show promise for treatment and prevention.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Biochemistry

Background:

  • Anthrax, caused by Bacillus anthracis, is a highly fatal infectious disease.
  • Despite available antimicrobial agents, anthrax mortality rates remain high.
  • B. anthracis pathogenicity is primarily attributed to its toxins (protective antigen, edema factor, lethal factor) and capsule.

Purpose of the Study:

  • To review novel therapeutic strategies targeting B. anthracis virulence factors.
  • To explore potential prophylactic measures and diagnostic applications for anthrax.
  • To assess recent patent prospects for anthrax countermeasures.

Main Methods:

  • Literature review of scientific publications and patents.
  • Analysis of B. anthracis virulence components and their roles in pathogenesis.
  • Evaluation of emerging therapeutic and diagnostic approaches.

Main Results:

  • Identification of key virulence factors: protective antigen (PA), edema factor (EF), lethal factor (LF), and capsule.
  • Investigation into novel therapies aimed at neutralizing these components.
  • Exploration of patent landscape for innovative anthrax treatments and diagnostics.

Conclusions:

  • Targeting B. anthracis virulence factors offers a promising strategy to combat anthrax.
  • Novel therapeutics and diagnostics are crucial to supplement existing antimicrobial treatments.
  • Recent patents indicate significant progress in developing effective anthrax countermeasures.

More Related Videos

An In Vitro Caseum Binding Assay that Predicts Drug Penetration in Tuberculosis Lesions12:17

An In Vitro Caseum Binding Assay that Predicts Drug Penetration in Tuberculosis Lesions

Published on: May 8, 2017

11.4K
Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments07:50

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments

Published on: October 25, 2024

2.0K

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
84
Production of Antibiotics01:27

Production of Antibiotics

Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
245
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K
Production of Pharmaceuticals01:30

Production of Pharmaceuticals

Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under...
90
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.7K
Automated Microbial Diagnostics01:24

Automated Microbial Diagnostics

Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...
65